Advancing Organoid Research: From Mechanistic Insights to Translational Applications

Organoid models enable human-centric investigation of biological mechanisms. Among many applications, organoids are used to assess safety in preclinical drug development and to discover new bioactive compounds. Yet translating their potential into reliable, scalable applications requires robust and reproducible 3D cell culture technologies.  

Join us on Thursday, November 19, 2026, at 10:00 am EST / 4:00 pm CET for a webinar featuring scientific perspectives and real-world applications from researchers at Novartis and Nestlé.

Our guest speakers, Audrey Fischer-Dietz and Dr. Omid Mashinchian, will share insights from their research, exploring how advanced organoid models are being applied to pharmaceutical safety assessment and the development of scalable organoid platforms. Through their experiences, attendees will gain a deeper understanding of the opportunities, practical considerations, and potential of organoid-based approaches in industry research.

Following these application-focused presentations, Sylke Höhnle-Ka, Co-founder of Gri3D®, will introduce the technology behind Gri3D® Hydrogel Microcavity Plates and explain how the platform enables reproducible 3D cell culture across diverse biological models and applications.

Whether you are interested in mechanistic studies, advanced 3D models, or scalable organoid applications, this webinar will provide practical insights from industry scientists and explore how organoid technologies are advancing translational research.